Radiation Therapy

targeted radiosurgery, stereotactic radiosurgery, whole-brain radiation, brain tumor metastases, Cureus, University of Missouri School of Medicine study
News | Radiation Therapy | February 16, 2017

University of Missouri (MU) School of Medicine researchers compared two common postsurgical therapies for metastatic...

ASTRO guideline, bone metastases, pallliative radiation therapy, gold standard
News | Radiation Therapy | February 14, 2017

February 14, 2017 — The American Society for Radiation Oncology (ASTRO) recently published an updated clinical...

Accuray, Radixact treatment delivery system, TomoTherapy, Shonin approval, Japan
News | Radiation Therapy | February 13, 2017

February 13, 2017 — Accuray Inc.

state of the proton therapy market entering 2017, proton therapy, radiation therapy, Robust Insight survey
News | Proton Therapy | February 10, 2017

Independent market research consultancy Robust Insight recently conveyed a survey commissioned by IBA on the state...

EGFR mutant lung cancer, brain metastases, order of treatment, radiation therapy, EGFR-directed drugs, Journal of Clinical Oncology study
News | Lung Cancer | February 09, 2017

February 9, 2017 — A study published in the...

IBA, Dolphin Online Ready Patient QA and Monitoring solution, radiotherapy, North West Cancer Centre, Londonderry, Northern Ireland, first in U.K.
News | Radiation Therapy | February 07, 2017

IBA (Ion Beam Applications S.A.) recently announced the first clinical implementation of its Dolphin Online Ready...

Institut Curie, Onxeo, radiotherapy, immunotherapy, DNA repair inhibitors, AsiDNA, DBait
News | Radiation Therapy | February 06, 2017

Onxeo S.A. and the Institut Curie launched a series of studies on World Cancer Day (Feb. 4) aimed at investigating...

radiotargeted therapy, SST2 antagonists, combat cancer, neuroendocrine tumors, NETs, Journal of Nuclear Medicine study

Comparative receptor autoradiography in various cancer types (A = HE staining) with I-125-JR11 (B+C) and I-125-Tyr3-octreotide (D+E). B and D are the respective total binding, C and E the respective non-specific binding. Bars = 1 mm.

I: Breast cancer. II: Renal cell cancer. III: Medullary thyroid cancer. IV: Non-Hodgkin lymphoma. V: Colon cancer. In cancers I-V, the sections were incubated with 30’000 cpm/100 μl of antagonist or agonist. Cancers I-IV show a much higher density of sst2 with the antagonist. The colon cancer V is negative. VI: Ileal NET, incubated with 10’000 cpm/100 μl of antagonist or agonist. Credit: Jean Claude Reubi, Institute of Pathology, University of Berne, Berne, Switzerland. 

News | Radiation Therapy | February 06, 2017

A study published in the February issue of The Journal of Nuclear Medicine demonstrates the potential of extending...

recurrent prostate cancer, hormone therapy, radiation therapy, Cedars-Sinai study, New England Journal of Medicine
News | Prostate Cancer | February 03, 2017

Adding hormonal therapy to radiation treatment can significantly improve the average long-term survival of men with...

insightec exablate high intensity focused ultrasound system

The InSightec ExAblate focused ultrasound system developed to treat essential tremor. Studies are underway to see if FUS can be used to treat other brain conditions and brain cancer.

Feature | Focused Ultrasound Therapy | February 03, 2017 | Dave Fornell

Focused ultrasound (FUS), also called high-intensity focused ultrasound (HIFU), has gained a lot of interest in...

ASTRO, lawmakers, healthcare access, insurance coverage, Congress, radiation therapy
News | Radiation Therapy | February 03, 2017

As the new Congress and administration wrestle with policy decisions on the provision of high-quality, affordable...

RayStation 6, new release, RaySearch Laboratories, radiation therapy, treatment planning, TomoTherapy
Technology | Treatment Planning | February 01, 2017

RayStation 6, the latest release of RaySearch’s radiation therapy treatment planning system, adds significant new...

RayStation, radiation therapy, treatment planning system, University of Wisconsin Madison
News | Treatment Planning | January 30, 2017

The Department of Human Oncology at the University of Wisconsin-Madison has chosen RayStation as its next radiation...

Mevion S250 proton therapy system, UF Health Cancer Center - Orlando Health, Airo CT scanner, Veritiy Patient Positioning System, radiation therapy
News | Proton Therapy | January 27, 2017

Mevion Medical Systems and UF Health Cancer Center - Orlando Health recently announced the first patient treatment...

Accuray, Radixact Treatment Delivery System, Miami Cancer Institute, first patients
News | Radiation Therapy | January 26, 2017

Accuray Inc. announced recently that Miami Cancer Institute, a part of Baptist Health South Florida, is now treating...

Elekta Gamma Knife, hypofractionated radiosurgery, large or complex brain tumors, Journal of Neurosurgery study
News | Radiation Therapy | January 25, 2017

Elekta announced new data demonstrating Leksell Gamma Knife better spares healthy brain tissue and delivers a higher...

MRgFUS
News | Focused Ultrasound Therapy | January 17, 2017

Insightec, a leader in MR-guided focused ultrasound (MRgFUS) therapy, announced today that the Japanese Ministry of...

Elekta, Esteya electronic brachytherapy system, Radiation Oncology Centres, first in Australia, skin cancer
News | Brachytherapy Systems | January 16, 2017

On Dec. 8, 2016, a female patient in her 60s became the first in the Australia/New Zealand region to receive...

Overlay Init